Thomas N. Tozer

4.0k total citations · 1 hit paper
71 papers, 3.2k citations indexed

About

Thomas N. Tozer is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Analytical Chemistry. According to data from OpenAlex, Thomas N. Tozer has authored 71 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Pediatrics, Perinatology and Child Health and 12 papers in Analytical Chemistry. Recurrent topics in Thomas N. Tozer's work include Pharmacogenetics and Drug Metabolism (10 papers), Analytical Methods in Pharmaceuticals (10 papers) and Pharmaceutical studies and practices (8 papers). Thomas N. Tozer is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Analytical Methods in Pharmaceuticals (10 papers) and Pharmaceutical studies and practices (8 papers). Thomas N. Tozer collaborates with scholars based in United States, Thailand and France. Thomas N. Tozer's co-authors include Norton H. Neff, Bernard B. Brodie, Susan M. Pond, Malcolm Rowland, Svein Øie, Frédéric Y. Bois, David R. Friend, Andrew McLeod, L. Dallas Tuck and Sidney Riegelman and has published in prestigious journals such as Science, The Journal of Chemical Physics and Gastroenterology.

In The Last Decade

Thomas N. Tozer

70 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

First-Pass Elimination

1984 341 citations Susan M. Pond, Thomas N. Tozer profile →

Peers

Countries citing papers authored by Thomas N. Tozer

Since Specialization

Citations

This map shows the geographic impact of Thomas N. Tozer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas N. Tozer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas N. Tozer more than expected).

Fields of papers citing papers by Thomas N. Tozer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas N. Tozer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas N. Tozer. The network helps show where Thomas N. Tozer may publish in the future.

Co-authorship network of co-authors of Thomas N. Tozer

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas N. Tozer. A scholar is included among the top collaborators of Thomas N. Tozer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas N. Tozer. Thomas N. Tozer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Considerations in the Attainment of Steady State: Aggregate vs. Individual Assessment 1998 ·Pharmaceutical Research ·Walter W. Hauck, Thomas N. Tozer, Sharon Anderson, Frédéric Y. Bois	6
2	Absorption Rate Vs. Exposure: Which Is More Useful for Bioequivalence Testing? 1996 ·Pharmaceutical Research ·Thomas N. Tozer, Frédéric Y. Bois, Walter W. Hauck, Mei‐Ling Chen, Roger Williams	42
3	Glucocorticoid‐dextran conjugates as potential prodrugs for colonspecific delivery: Steady‐state pharmacokinetics in the rat 1994 ·Biopharmaceutics & Drug Disposition ·Andrew McLeod, Lorna Tolentino, Thomas N. Tozer	32
4	Bioequivalence: Performance of Several Measures of Extent of Absorption 1994 ·Pharmaceutical Research ·Frédéric Y. Bois, Thomas N. Tozer, Walter W. Hauck, Mei‐Ling Chen, Rabindra Patnaik, Roger Williams	54
5	A glucocorticoid prodrug facilitates normal mucosal function in rat colitis without adrenal suppression 1994 ·Gastroenterology ·Andrew McLeod, Richard N. Fedorak, David R. Friend, Thomas N. Tozer, Ningren Cui	38
6	Glucocorticoid–Dextran Conjugates as Potential Prodrugs for Colon-Specific Delivery: Hydrolysis in Rat Gastrointestinal Tract Contents 1994 ·Journal of Pharmaceutical Sciences ·Andrew McLeod, David R. Friend, Thomas N. Tozer	80
7	Pharmacokinetic Concepts in Assessing Intake of Pentachlorophenol by Rats after Exposure through Drinking Water 1992 ·Journal of Pharmaceutical Sciences ·Bruno Reigner, (unknown), Frédéric Y. Bois, Lauren Zeise, Thomas N. Tozer	4
8	Colon-Specific Delivery of Dexamethasone from a Glucoside Prodrug in the Guinea Pig 1991 ·Pharmaceutical Research ·Thomas N. Tozer, (unknown), Andrew McLeod, (unknown), (unknown), David R. Friend	40
9	Theoretical model for both saturable rate and extent of absorption: Simulations of cefatrizine data 1991 ·Journal of Pharmacokinetics and Biopharmaceutics ·William Couet, Bruno Reigner, (unknown), Thomas N. Tozer	14
10	Saturable rate of cefatrizine absorption after oral administration to humans 1990 ·Journal of Pharmacokinetics and Biopharmaceutics ·Bruno Reigner, William Couet, (unknown), (unknown), Thomas N. Tozer	18
11	Teicoplanin pharmacokinetics and bioavailability during peritoneal dialysis 1989 ·Clinical Pharmacology & Therapeutics ·R. Brouard, (unknown), John G. Gambertoglio, Patricia Schoenfeld, Meena Sachdeva, (unknown), Thomas N. Tozer	9
12	Time-dependent, plasma-sulfate-independent kinetics of salicylamide in dogs 1988 ·Journal of Pharmacokinetics and Biopharmaceutics ·James A. Waschek, Robert M. Fielding, Thomas N. Tozer, David J. Effeney, Susan M. Pond	0
13	Non-linear hepatic first-pass metabolism of salicylamide in dogs after portacaval transposition 1988 ·Journal of Pharmacokinetics and Biopharmaceutics ·Susan M. Pond, Varocha Mahachai, David J. Effeney, Thomas N. Tozer	1
14	Concurrent intravenous administration of a labeled tracer to determine the oral bioavailability of a drug exhibiting Michaelis-Menten metabolism 1987 ·Journal of Pharmacokinetics and Biopharmaceutics ·Gerald M. Rubin, James A. Waschek, Susan M. Pond, David J. Effeney, Thomas N. Tozer	15
15	Pharmacokinetics of Two Prototype Nitroxide Spin Labels for Contrast Enhancement in Magnetic Resonance Imaging 1985 ·Pharmaceutical Research ·William Couet, Ulf G. Eriksson, Robert C. Brasch, Thomas N. Tozer	17
16	Correction for Volume Shift during Equilibrium Dialysis by Measurement of Protein Concentration 1984 ·Pharmaceutical Research ·Kathleen M. Giacomini, (unknown), Thomas N. Tozer	17
17	Pharmacokinetics and Metabolic Fate of Two Nitroxides Potentially Useful as Contrast Agents for Magnetic Resonance Imaging 1984 ·Pharmaceutical Research ·William Couet, Ulf G. Eriksson, Thomas N. Tozer, L. Dallas Tuck, George Wesbey, Danute E. Nitecki, Robert C. Brasch	67
18	Renal function and therapeutic concentrations of phenytoin 1984 ·Neurology ·(unknown), Michael E. Winter, Thomas N. Tozer	31
19	Brain Nuclear Magnetic Resonance Imaging Enhanced by a Paramagnetic Nitroxide Contrast Agent: Preliminary Report 1983 ·American Journal of Neuroradiology ·Robert C. Brasch, Danute E. Nitecki, Michael Brant‐Zawadzki, Dieter R. Enzmann, George Wesbey, Thomas N. Tozer, L. Dallas Tuck, Christopher E. Cann, John R. Fike, (unknown)	7
20	APPLICATION OF STEADY STATE KINETICS TO THE SYNTHESIS RATE AND TURNOVER TIME OF SEROTONIN IN THE BRAIN OF NORMAL AND RESERPINE-TREATED RATS 1966 ·Journal of Pharmacology and Experimental Therapeutics ·Thomas N. Tozer, Norton H. Neff, Bernard B. Brodie	258

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact